Last week, Jessica Resnick gave a seminar on her successfully completed and defended thesis research, Viral and host determinants of Influenza A and SARS-CoV-2 virus temperature-dependent replication. Congratulations, Jessica!

Dr. Andrew Pekosz and Dr. Jaiprasath Sachithanandham were part of a group of Johns Hopkins researchers who received a letter this week from the director of the National Institute of Allergies and Infectious Diseases, Dr. Anthony Fauci. Dr. Fauci recognized their work in sequencing and isolating emerging SARS-CoV-2 variants alongside collaborators from the School of Medicine, especially Dr. Heba Mostafa.

This group also recently put out a paper in the Lancet’s eBioMedicine, “The Displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads.” You can read it here.

Position description below.

[IMAGE TEXT: Postdoctoral Associate Position to Study Respiratory Virus-Epithelial Cell Interactions. A position is available to study SARS-CoV-2 infection of primary differentiated human nasal epithelial cell (hNEC) cultures. SARS-CoV-2 infects the upper and lower respiratory tract and replication can be influenced by physiological ranges in temperature (33C to 37C). This project will study both viral and cellular factors that mediate changes in replication rates and epithelial cell responses to infection. The isolation of variants of concern coupled with an infectious clone system will be utilized to study mutations in SARS-CoV-2 structural and nonstructural proteins and how they affect virus fitness. Candidates with a strong background in virology, molecular biology, and/or biochemistry should send a cover letter, CV, and the names/email addresses of three references to: Andrew Pekosz, Ph.D., W. Harry Feinstone Department of Molecular Microbiology & Immunology, Johns Hopkins University Bloomberg School of Public Health, 615 North Wolfe Street room W2116, Baltimore, MD 21205-2103. Email: apekosz1@jhu.edu]

Several members of the Pekosz lab were authors on a paper published in the Journal of Clinical Investigation last month “Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.” This paper characterized immune responses to infection by the Alpha variant of SARS-CoV-2.

Dr. Pekosz’s guest essay was recently featured in the New York Times, discussing the present and future of disease severity caused by SARS-CoV-19 variants.

Covid-19 becoming a milder disease is not a decision the virus will make, it’s a decision that all of us can make if we take advantage of the vaccines that can control spread and reduce disease burden

Read the essay here.